Sanofi - Stock Price History | SNY

Historical daily share price chart and data for Sanofi since 2019 adjusted for splits. The latest closing stock price for Sanofi as of October 14, 2019 is 44.89.
  • The all-time high Sanofi stock closing price was 57.29 on September 22, 2014.
  • The Sanofi 52-week high stock price is 47.11, which is 4.9% above the current share price.
  • The Sanofi 52-week low stock price is 40.00, which is 10.9% below the current share price.
  • The average Sanofi stock price for the last 52 weeks is 43.18.
Sanofi Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2018 41.9428 43.3200 45.7600 37.6300 43.4100 0.95%
2017 46.1928 41.0200 50.6100 39.5100 43.0000 6.33%
2016 40.1793 42.2000 44.3200 37.0600 40.4400 -5.18%
2015 48.8585 45.5200 54.9800 41.5100 42.6500 -6.49%
2014 51.4861 51.7500 57.2900 44.4000 45.6100 -14.95%
2013 51.1111 47.9200 55.6400 45.3000 53.6300 13.19%
2012 39.7206 37.2300 47.6300 33.4400 47.3800 29.67%
2011 35.6899 32.8200 40.5800 31.5000 36.5400 13.37%
2010 33.6045 40.8200 41.5500 28.2600 32.2300 -17.93%
2009 32.6672 32.6900 40.3800 25.0200 39.2700 22.11%
2008 35.2888 45.6400 48.7800 25.3800 32.1600 -29.37%
2007 43.7968 46.1400 48.2400 38.6000 45.5300 -1.39%
2006 45.4090 45.6300 50.0000 41.8800 46.1700 5.17%
2005 41.7475 39.8000 45.8400 36.7600 43.9000 9.61%
2004 34.8101 38.0600 40.4500 29.3600 40.0500 6.09%
2003 29.7702 31.0400 37.7500 22.8000 37.7500 24.18%
2002 29.4331 29.7700 32.1000 25.9100 30.4000 0.00%
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $112.561B $40.701B
Sanofi-Aventis is a global pharmaceutical company that contributes to enhance life by providing medicines, vaccines, and integrated healthcare solutions adapted to local needs and means primarily in Europe and the United States. The company is engaged in the research, development, manufacture and marketing of healthcare products. Its strategy is built around three priorities to reach its goals and ensure sustainable growth. The priorities are: increasing innovation in Research and Development, adapting Group structures to future challenges and seizing external growth opportunities. Sanofi-Aventis specializes in six therapeutic areas: thrombosis, cardiovascular, metabolic disorders, oncology, central nervous system (CNS) and internal medicine. The Company offers vaccines in five areas: pediatric combination vaccines, influenza vaccines, adult and adolescent booster vaccines, meningitis vaccines, and travel and endemic vaccines. Sanofi-Aventis is headquartered in Paris, France.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $346.602B 15.10
Roche Holding AG (RHHBY) Switzerland $247.573B 0.00
Merck (MRK) United States $215.942B 17.76
Pfizer (PFE) United States $199.726B 11.76
Novartis AG (NVS) Switzerland $198.470B 17.08
Novo Nordisk (NVO) Denmark $121.313B 21.43
AstraZeneca (AZN) United Kingdom $114.344B 22.12
AbbVie (ABBV) United States $108.861B 8.72
GlaxoSmithKline (GSK) United Kingdom $105.206B 13.22
Eli Lilly (LLY) United States $104.614B 19.52
Bristol-Myers Squibb (BMY) United States $84.422B 11.97
Bayer (BAYRY) Germany $66.771B 9.73
H Lundbeck (HLUYY) Denmark $6.541B 9.44